Satan, Prince of this World: An overview of Chapter 6 & 7

By Rhoda Wilson on February 20, 2026

Secret societies, such as Freemasonry, play a significant role in the implementation of the Luciferian conspiracy, but few realise that the Synagogue of Satan, also known as the Illuminati, controls them at the top.

Illuminism has existed since the time of Cain, but, as requested by the Rothschilds, Adam Weishaupt modernised the luciferian Protocols in 1776 and organised the Illuminati to put the revised version of the conspiracy into effect.

The Protocols are the original draft of the plan for a One World Government, via the United Nations, and a One World Religion, which will be used to impose the luciferian ideology on all of mankind.

The luciferian conspiracy, directed by the Synagogue of Satan, uses deceit to divide people and shift blame for their crimes, and so keeping their motives and identity secret.

more:

https://expose-news.com/2026/02/20/satan-prince-of-this-world-chapter-6-7/

FDA's Straight Shooter: Don't Bring Crappy Data To A Gunfight

Inside Vinay Prasad's standoff with Moderna

Emily Kopp

Feb 18, 2026

For years the Food and Drug Administration has handed down shocking decision after shocking decision, always in the same direction: The approval of Alzheimer’s drugs that are balanced precariously on a mountain of fraudulent papers and that sometimes make your brain explode; the approval of OxyContin for 11-year-olds; the approval of COVID-19 booster shots in healthy young people in order to please the political science majors in the White House.

But there’s a new sheriff in town, and he’s made a lot of powerful enemies already reining in a lawless pharmaceutical industry.

“Vinay Prasad’s Vaccine Kill Shot,” the Wall Street Journal editorial board shrieked on Feb. 11, referring to the decision by the FDA’s new chief vaccine regulator to send back a study of Moderna’s mRNA flu vaccine with a grade of incomplete, saying it does not meet the standards of an “adequate and well-controlled” study.

Prasad, the head of FDA’s Center for Biologics Evaluation and Research, personally signed a Feb. 3 “refusal to file,” a formal refusal to review Moderna’s clinical trial — a regulatory middle finger.

“I feel like the word ‘surprised’ gets used a lot in the company communications we see,” said Drew Armstrong, executive editor of the pharma trade publication Endpoints News, on a podcast following the decision.

But the FDA makes shocking decisions all the time. What’s novel this time — provoking an unusual rebuke by Moderna and a media meltdown — is that the decision defies pharma influence rather than capitulating to it.

more:

https://www.racket.news/p/fdas-straight-shooter-dont-bring